NCT03774199 (NPOCS) is a NA clinical trial of NightOwl in Pulse Oximeter Calibration, sponsored by Ectosense NV.

Who is sponsoring NCT03774199?

NCT03774199 is sponsored by Ectosense NV.

What drugs are being tested in NCT03774199?

Interventions in NCT03774199: NightOwl.

What condition does NCT03774199 study?

NCT03774199 studies Pulse Oximeter Calibration.

Is NCT03774199 still recruiting?

NCT03774199 is currently status unknown. Last updated 21 March 2019.

Last reviewed 2019-03-21 · How we verify

NCT03774199: NPOCS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NightOwl Pulse Oximeter Calibration Study

Status unknown NA Last updated 21 March 2019

What this trial tests

NA trial testing NightOwl in Pulse Oximeter Calibration in 30 participants. Status unknown.

Timeline

14 December 2018

Primary endpoint
14 December 2019

14 April 2020

Quick facts

Lead sponsor	Ectosense NV
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	30
Start date	14 December 2018
Primary completion	14 December 2019
Estimated completion	14 April 2020
Sites	1 location across Belgium

Drugs / interventions tested

NightOwl

Conditions studied

Pulse Oximeter Calibration — all drugs for Pulse Oximeter Calibration →

Sponsor

Ectosense NV

Who can join

13 and older, any sex, with Pulse Oximeter Calibration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Calibration of a software module that computes SpO2 based on photoplethysmography (PPG) traces acquired by a reflectance-based pulse oximeter which can be placed on the index finger or the forehead. The study is designed in accordance with Medical electrical equipment - Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment (ISO 80601- 2-61:2011)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of NightOwl

Trials testing the same drug.

NCT06264427 — Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland · NA · recruiting
NCT04764734 — A Validation Study of the NightOwl Home Sleep Apnea Test · NA · unknown
NCT04760002 — DANish Patients With Atrial Fibrillation and Sleep Apnea Prevalence by Night Owl · completed
NCT04191668 — A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test · NA · completed

Other Ectosense NV trials

Trials by the same sponsor.

NCT04764734 — A Validation Study of the NightOwl Home Sleep Apnea Test · NA · unknown
NCT04191668 — A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test · NA · completed
NCT03635918 — Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test · NA · unknown
NCT03385187 — Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03774199 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ectosense NV
Last refreshed: 21 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03774199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing